arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Celcuity Inc.

CELC Health Care Medical Specialities
$65.57
▲ +9.3% Today
as of Oct 22, 16:47 ET
Last 30 days -21.50% Sep 14 → Oct 22
$54.31 $62.53 $70.75 $78.96 $87.18 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$61.74
High
$66.93
Low
$61.74
Volume
$2M
Avg Vol
$1M
Mkt Cap
$3.7B
P/E (TTM)
—
Beta
—
52w High
$151.02
52w Low
$53.54
Div Yield
—
Shares Out
$49M

Recent Press Releases & News last 60 days · 14 items

Oct 22 · 12:26 MT Newswires
Cantor Fitzgerald Initiates Celcuity at Overweight With $140 Price Target
Oct 18 · 19:11 Simply Wall St.
Celcuity (CELC) Stock May Be Hard To Value On Book Value
Oct 8 · 01:14 Simply Wall St.
Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News Event
▸ Show all 14 press releases & news Free account →

CELC earnings at a glance

The options market is pricing a move of about ±8.6% after the report, a range of roughly $59.92 to $71.22 from today's $65.57. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±4.3% on average; after the most recent report on May 14, 2026 it moved +8.2%. That means options currently expect more movement than CELC has typically delivered. CELC beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 73%. The share price of $65.57 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$54
$151
12% of range
Avg surprise (last 4)
+3.9%
Avg reaction (last 2)
+4.3%
100% positive
Latest IV / EM
73%
EM ±8.6% · $70 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.44$-1.22$-0.99$-0.77$-0.55 Actual $-0.55Actual $-0.66Actual $-0.83Actual $-0.64Actual $-0.62Actual $-0.70Actual $-0.86Est $-0.95Actual $-1.04Est $-0.90Actual $-0.92Est $-1.05Actual $-0.97Est $-1.07Actual $-1.44 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-79M$-67M$-55M$-43M$-31M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.44 — — — — financials
Thu May 14, 2026Mar/2026 $-0.97 $-1.07 +9.3% -12.8% +8.2% earnings
Wed Nov 12, 2025Sep/2025 $-0.92 $-1.05 +12.4% — — earnings
Thu Aug 14, 2025Jun/2025 $-1.04 $-0.90 -15.6% — — earnings
Wed May 14, 2025Mar/2025 $-0.86 $-0.95 +9.5% — +0.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.70 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.62 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.64 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.83 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.66 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.55 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-66M$-51M—$-43M$-44M$-36M—$-30M
Net income$-79M$-53M—$-44M$-45M$-37M—$-30M
EPS (diluted)$-1.44$-0.97—$-0.92$-1.04$-0.86—$-0.70

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$182M$145M$166M$74M$46M$16M$23M$13M
Inventory————————
Total current assets$776M$409M$466M$475M$183M$218M$245M$272M
Total assets$828M$410M$467M$476M$184M$218M$245M$273M
Long-term debt$0$138M—$137M$106M$105M—$105M
Total liabilities$841M$357M$366M$359M$139M$131M$130M$123M
Total equity$-13M$54M$101M$117M$44M$87M$116M$150M

Implied volatility — last 90 days

45%70%94%119%143% Jun 07 — IV 79% · EM ±10.9%Jun 08 — IV 79% · EM ±10.4%Jun 09 — IV 76% · EM ±9.6%Jun 10 — IV 77% · EM ±9.2%Jun 11 — IV 72% · EM ±8.0%Jun 12 — IV 72% · EM ±7.4%Jun 15 — IV 82% · EM ±5.9%Jun 16 — IV 143% · EM ±8.5%Jun 17 — IV 114% · EM ±4.7%Jun 19 — IV 68% · EM ±15.0%Jun 22 — IV 74% · EM ±15.4%Jun 23 — IV 71% · EM ±14.5%Jun 24 — IV 70% · EM ±14.1%Jun 25 — IV 77% · EM ±15.1%Jun 26 — IV 78% · EM ±15.0%Jun 29 — IV 82% · EM ±14.6%Jun 30 — IV 76% · EM ±13.1%Jul 01 — IV 70% · EM ±11.7%Jul 02 — IV 77% · EM ±12.5%Jul 03 — IV 80% · EM ±12.5%Jul 06 — IV 66% · EM ±9.1%Jul 07 — IV 71% · EM ±9.3%Jul 08 — IV 86% · EM ±10.8%Jul 09 — IV 90% · EM ±10.7%Jul 10 — IV 86% · EM ±9.5%Jul 13 — IV 113% · EM ±9.4%Jul 14 — IV 96% · EM ±6.9%Jul 15 — IV 130% · EM ±7.7%Jul 16 — IV 134% · EM ±5.6%Jul 20 — IV 78% · EM ±18.5%Jul 21 — IV 75% · EM ±17.5%Jul 22 — IV 75% · EM ±17.2%Jul 23 — IV 71% · EM ±16.0%Jul 24 — IV 74% · EM ±16.5%Jul 27 — IV 73% · EM ±15.3%Jul 28 — IV 76% · EM ±15.5%Jul 29 — IV 77% · EM ±15.5%Jul 30 — IV 77% · EM ±15.1%Jul 31 — IV 72% · EM ±13.8%Aug 03 — IV 79% · EM ±14.0%Aug 04 — IV 81% · EM ±14.0%Aug 05 — IV 82% · EM ±13.7%Aug 06 — IV 80% · EM ±13.0%Aug 07 — IV 82% · EM ±12.8%Aug 10 — IV 82% · EM ±11.3%Aug 11 — IV 84% · EM ±11.0%Aug 12 — IV 79% · EM ±9.9%Aug 13 — IV 80% · EM ±9.4%Aug 14 — IV 66% · EM ±7.3%Aug 17 — IV 79% · EM ±6.6%Aug 18 — IV 64% · EM ±4.6%Aug 19 — IV 67% · EM ±4.0%Aug 20 — IV 84% · EM ±3.5%Aug 24 — IV 59% · EM ±12.3%Aug 25 — IV 56% · EM ±11.5%Aug 26 — IV 46% · EM ±9.2%Aug 27 — IV 59% · EM ±11.5%Aug 28 — IV 48% · EM ±9.3%Aug 31 — IV 53% · EM ±9.4%Sep 01 — IV 49% · EM ±8.4%Sep 02 — IV 55% · EM ±9.1%Sep 03 — IV 52% · EM ±8.4%Sep 04 — IV 48% · EM ±7.4%Sep 07 — IV 54% · EM ±7.4%Sep 08 — IV 52% · EM ±6.9%Sep 09 — IV 61% · EM ±7.7%Sep 10 — IV 57% · EM ±6.8%Sep 11 — IV 50% · EM ±5.5%Sep 14 — IV 75% · EM ±6.3%Sep 15 — IV 119% · EM ±8.6%Sep 16 — IV 116% · EM ±6.8%Sep 17 — IV 85% · EM ±3.5%Sep 21 — IV 63% · EM ±13.1%Sep 22 — IV 57% · EM ±11.7%Sep 23 — IV 56% · EM ±11.3%Sep 24 — IV 57% · EM ±11.1%Sep 25 — IV 58% · EM ±11.1%Sep 28 — IV 60% · EM ±10.5%Sep 29 — IV 67% · EM ±11.5%Sep 30 — IV 56% · EM ±9.3%Oct 01 — IV 47% · EM ±7.6%Oct 02 — IV 46% · EM ±7.2%Oct 06 — IV 53% · EM ±7.0%Oct 07 — IV 69% · EM ±8.7%Oct 08 — IV 73% · EM ±8.6%

Sector peers

VCYT
Veracyte, Inc.
$3.5B $46.04+2.8%
CDNA
CareDx, Inc.
$3.3B $69.16-0.1%
ACHC
Acadia Healthcare Company, Inc.
$2.7B $31.88+1.4%
CON
Concentra Group Holdings Parent, Inc.
$4.6B $39.97+3.1%
CLOV
Clover Health Investments, Corp.
$2.4B $4.73-1.5%
VRDN
Viridian Therapeutics, Inc.
$2.1B $22.82+1.7%

CELC earnings FAQ

What is CELC's expected move for earnings?

Options currently price a move of about ±8.6%, or $5.65 per share either way from $65.57.

How does CELC stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.3%, up 2 times and down 0 times.

What is CELC's implied volatility?

CELC's at-the-money implied volatility is about 73% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in